VA

Vishal Amol Gavekar

Active Director Director DIN 10200351
DIN 10200351 First appointment Jun 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Vishal Amol Gavekar

Data last updated:

Vishal Amol Gavekar is a Director at Ketogens Healthcare Private Limited (since 2023).

DIN 10200351
Primary Designation Director
First Appointment 15 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ketogens Healthcare Private Limited U47721MH2023PTC404716
Director15 Jun 20232023Active

Board colleagues of Vishal Amol Gavekar

NameDINCompanyDesignation
Himanshu Verma07341336Ketogens Healthcare Private LimitedIndividual Subscriber
Rohit Anil Shetty09418235Ketogens Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ketogens Healthcare Private Limited
Premium access

Shareholding and investment profile for Vishal Amol Gavekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishal Amol Gavekar

Vishal Amol Gavekar currently holds 1 directorship: Ketogens Healthcare Private Limited (Director, since 15 Jun 2023).

Vishal Amol Gavekar was first appointed on 15 Jun 2023 as Director at Ketogens Healthcare Private Limited.

The current boards of Vishal Amol Gavekar's companies include Himanshu Verma (Ketogens Healthcare Private Limited), Rohit Anil Shetty (Ketogens Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available